Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gary Mintz

Washington, DC Medical Doctor

NPI 1225307523 CMS profile 282184

822 E Capitol St Ne, Washington, DC 20003

Open in the dashboard

General payments

$451,004

127 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$502,172

3 holdings reported · through program year 2025

Through program year 2025, Gary Mintz of Washington, DC is reported in the CMS Open Payments database as having received $451,004 across 127 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $502,172 across 3 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $37,310 10
2024 General $31,030 15
2023 General $38,324 21
2022 General $101,009 23
2021 General $78,718 15
2020 General $107,051 25
2019 General $57,563 18
2025 Ownership $167,391 1
2024 Ownership $167,391 1
2023 Ownership $167,391 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gary Mintz
  • District of Columbia median
  • Middle half of District of Columbia
  • National median

In program year 2025, general payments to Gary Mintz were reported at $37,310. Among 3,939 District of Columbia profiles paid that year, the median was $152 and the middle half received between $48 and $589.

Show as a table
Year Gary Mintz District of Columbia median Middle half National median
2019 $57,563 $171 $49–$733 $163
2020 $107,051 $122 $37–$508 $114
2021 $78,718 $123 $34–$501 $132
2022 $101,009 $147 $40–$541 $149
2023 $38,324 $152 $46–$653 $160
2024 $31,030 $153 $46–$657 $164
2025 $37,310 $152 $48–$589 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $335,685 80 payments
  2. Medtronic Vascular, Inc. $100,588 26 payments
  3. Abbott Laboratories $5,057 2 payments
  4. SpectraWAVE, Inc $4,178 8 payments
  5. Gentuity, LLC $2,906 4 payments
  6. Philips Electronics North America Corporation $1,611 2 payments
  7. Terumo Medical Corporation $500 1 payment
  8. Medtronic, Inc. $357 3 payments
  9. Penumbra, Inc. $124 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $308,188 52 payments
  2. Consulting Fee $114,300 19 payments
  3. Travel and Lodging $23,804 23 payments
  4. Food and Beverage $4,213 32 payments
  5. Grant $500 1 payment
Products named General payments · program years 2019–2025
  1. General - Therapies General - Therapies_IC $75,847 12 payments
  2. Resolute $64,996 9 payments
  3. General - Vascular Access General - Vascular Access_IC $46,240 9 payments
  4. GENERAL VASCULAR ACCESS Pain Management $42,938 10 payments
  5. General Therapies $39,261 6 payments
  6. OPTICROSS $26,000 3 payments
  7. GENERAL - VASCULAR ACCESS Vascular $19,688 7 payments
  8. GENERAL ULTRASOUND $9,780 2 payments
  9. GENERAL VASCULAR ACCESS Vascular $7,446 2 payments
  10. General - Therapies Therapies $7,272 3 payments
  11. Other $25,025 45 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

127 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record